Therefore, we speculated that TLR2 interference can similarly regulate tumor microenvironment so as to minimize pan-cancer cell growth and attenuate metastasis, which would be a good candidate of pancreatic cancer medical therapy. The gene discussed is TLR2; the disease is familial pancreatic carcinoma.